CareRx Corp
F:29C1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CareRx Corp
F:29C1
|
CA |
|
Percheron Therapeutics Ltd
OTC:PERCF
|
AU |
|
I
|
Instadose Pharma Corp
OTC:INSD
|
US |
|
Tim SA
F:7G2
|
PL |
|
KYN Capital Group Inc
OTC:KYNC
|
US |
|
P
|
Prologic Management Systems Inc
OTC:PRLO
|
US |
|
M
|
MachTen Inc
OTC:MACT
|
US |
|
M
|
McChip Resources Inc
OTC:MCCHF
|
CA |
|
Otello Corporation ASA
F:OS3
|
NO |
|
LKA Gold Inc
OTC:LKAI
|
US |
|
Sarimelati Kencana Tbk PT
IDX:PZZA
|
ID |
|
C
|
CCID Consulting Co Ltd
F:CCX
|
CN |
|
Diamond Citra Propertindo Tbk PT
IDX:DADA
|
ID |
|
B
|
Bhatia Colour Chem Ltd
BSE:543497
|
IN |
|
M
|
Mercury Trade Links Ltd
BSE:512415
|
IN |
|
Trinitan Metals and Minerals Tbk PT
IDX:PURE
|
ID |
|
First Citizens National Bank of Upper Sandusky OH
OTC:FSDK
|
US |
|
E
|
Excel Corp
OTC:EXCC
|
US |
|
C
|
Chiangmai Rimdoi PCL
SET:CRD
|
TH |
|
Burcon NutraScience Corp
OTC:BRCND
|
CA |
|
I
|
Intelgenx Technologies Corp
F:0IL
|
CA |
|
Megawatt Lithium and Battery Metals Corp
F:WR2
|
CA |
|
M
|
Milisystem SA
WSE:MLM
|
PL |
|
Interpharm Holdings Inc
OTC:IPAH
|
US |
Wall St Price Targets
29C1 Price Targets Summary
CareRx Corp
According to Wall Street analysts, the average 1-year price target for 29C1 is 3.09 EUR with a low forecast of 2.53 EUR and a high forecast of 3.87 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 29C1's stock price target?
Price Target
3.09
EUR
According to Wall Street analysts, the average 1-year price target for 29C1 is 3.09 EUR with a low forecast of 2.53 EUR and a high forecast of 3.87 EUR.
What is the Revenue forecast for CareRx Corp?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for CareRx Corp?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -5%. The projected CAGR for the next 2 years is 6%.
What is the Operating Income forecast for CareRx Corp?
Projected CAGR
-25%
Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 2 years is -25%.
What is the Net Income forecast for CareRx Corp?
Projected CAGR
-32%
The compound annual growth rate for Net Income over the next 3 years is -32%.
